| Literature DB >> 32751090 |
Asmaa B Sabti1, Adil A Al-Fregi2, Majeed Y Yousif2.
Abstract
A novel series of organic tellurium compounds based on pyrazole derivatives with a general formula of ArTeBr3 and Ar2TeBr2 [Ar = 2-(3-(4-substituted phenyl)-5-(2-chlorophenyl)-1H-pyrazol-1-yl)-3,5-dinitrophenyl] were obtained by the refluxing of corresponding aryl mercuric chlorides with TeBr4 in two different mole ratio of 1:1 and 2:1, respectively, in free-moisture dioxane solvent under an argon atmosphere. Compounds of ArTeBr3 and Ar2TeBr2 were reduced by the action of ethanolic solution of hydrazine hydrate obtained Ar2Te2 and Ar2Te, respectively. Reaction of Ar2Te2 with excess thionyl chloride or iodine gave the corresponding trihalides ArTeCl3 and ArTeI3, respectively while the reaction of Ar2Te with thionyl chloride or iodine gave the corresponding Ar2TeCl3 and Ar2TeI3, respectively. The structures were elucidated according to their elemental analysis of carbon, hydrogen and nitrogen (CHN) and some of the spectroscopic techniques such as infrared IR and nuclear magnetic resonance for 1H and 13C. The antimicrobial activity for all the synthetic compounds were assayed against both Gram-negative and Gram-positive bacteria by using the agar diffusion method. The tellurated pyrazole derivatives showed a good degree against bacteria growth. In some cases, the antimicrobial activities of the synthetic compounds were better than amoxicillin.Entities:
Keywords: antimicrobial activities; organotellurium; pyrazoles; tellurium tetrabromide; transmetalltion reaction
Mesh:
Substances:
Year: 2020 PMID: 32751090 PMCID: PMC7435781 DOI: 10.3390/molecules25153439
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Scheme 1Preparative methods of compounds 1–3.
Scheme 2Preparative methods of compounds 4–15.
Scheme 3Preparative methods of compounds 16–21.
Scheme 4Preparative methods of compounds 22–27.
Figure 1General structure formula.
13C NMR chemical shifts for compounds 1–15 in DMSO-d6.
| Compound | Pyrazol Ring | Aryl Rings | Substituted Groups | ||||
|---|---|---|---|---|---|---|---|
| C3 | C4 | C5 | Te-C | Ar-H | CH3 | OCH3 | |
|
| 139.80 | 104.66 | 149.62 | 114.90 | 138.80–124.20 | ||
|
| 139.72 | 104.64 | 149.60 | 114.42 | 132.50–124.00 | 21.60 | |
|
| 139.74 | 104.64 | 149.61 | 114.46 | 163.20–121.15 | 56.00 | |
|
| 139.89 | 104.66 | 149.60 | 114.44 | 138.89–124.28 | ||
|
| 139.70 | 104.40 | 149.80 | 114.00 | 132.41–124.24 | 21.73 | |
|
| 139.77 | 104.43 | 149.82 | 114.06 | 163.41–124.70 | 56.60 | |
|
| 139.60 | 104.66 | 149.66 | 114.88 | 138.91–124.33 | ||
|
| 139.50 | 104.34 | 149.60 | 114.00 | 132.38–124.20 | 21.80 | |
|
| 139.52 | 104.34 | 149.62 | 114.06 | 163.41–124.74 | 55.58 | |
|
| 139.56 | 103.71 | 149.66 | 114.14 | 139.56–124.60 | ||
|
| 139.50 | 103.56 | 149.64 | 114.40 | 133.42–124.77 | 21.59 | |
|
| 139.50 | 103.60 | 149.64 | 114.31 | 163.00–124.00 | 55.60 | |
|
| 139.88 | 103.52 | 149.70 | 114.72 | 138.00–124.10 | ||
|
| 139.84 | 103.18 | 149.65 | 114.60 | 132.41–124.78 | 21.60 | |
|
| 139.86 | 103.43 | 149.65 | 114.65 | 163.43–124.77 | 55.59 | |
|
| 139.88 | 103.24 | 149.78 | 114.70 | 138.00–124.74 | ||
|
| 139.70 | 103.20 | 149.71 | 114.65 | 132.40–124.00 | 21.50 | |
|
| 139.52 | 103.20 | 149.63 | 114.66 | 163.45–124.50 | 55.51 | |
|
| 139.80 | 103.60 | 149.75 | 114.79 | 138..43–124.06 | ||
|
| 139.84 | 103.56 | 149.62 | 114.86 | 132.38–125.54 | 21.74 | |
|
| 139.77 | 103.45 | 149.64 | 114.75 | 163.03–124.12 | 55.59 | |
|
| 139.84 | 104.50 | 149.75 | 114.91 | 138.09–124.00 | ||
|
| 139.80 | 103.35 | 149.60 | 114.64 | 133.00–125.22 | 21.82 | |
|
| 139.63 | 104.34 | 149.66 | 114.80 | 163.00–124.66 | 55.60 | |
|
| 139.85 | 103.95 | 149.79 | 114.83 | 138.05–124.91 | ||
|
| 139.76 | 103.88 | 149.61 | 114.70 | 132.11–124.00 | 21.77 | |
|
| 139.65 | 103.89 | 149.60 | 114.76 | 163.40–124.99 | 55.60 | |
Inhibition zones (mm) of synthetic compounds 1–27.
| COMP. | Diameter of Inhibition Zone (mm) | |||
|---|---|---|---|---|
| Gram Positive Bacteria | Gram Negative Bacteria | |||
|
|
|
|
| |
|
| 18 | 16 | 19 | 13 |
|
| 14 | 11 | 15 | 10 |
|
| 18 | 14 | 16 | 12 |
|
| - * | - | - | - |
|
| - | - | - | - |
|
| - | - | - | 12 |
|
| 28 | 25 | 27 | 27 |
|
| 21 | 20 | 21 | 23 |
|
| 24 | 23 | 25 | 26 |
|
| 14 | 17 | 12 | 17 |
|
| - | - | 10 | 10 |
|
| 10 | 12 | 11 | 11 |
|
| 50 | 41 | 42 | 39 |
|
| 32 | 30 | 31 | 38 |
|
| 34 | 33 | 35 | 37 |
|
| - | - | - | - |
|
| - | - | - | - |
|
| - | - | - | - |
|
| - | - | - | - |
|
| - | - | - | - |
|
| - | - | - | - |
|
| 22 | 20 | 21 | 25 |
|
| 17 | 18 | 17 | 19 |
|
| 21 | 19 | 21 | 22 |
|
| 29 | 27 | 22 | 20 |
|
| 18 | 18 | 19 | 18 |
|
| 21 | 22 | 21 | 19 |
| DMSO | - | 10 | - | - |
| Amoxicillin | 30 | 30 | 30 | 30 |
*(-) indicates no activity.
Minimum inhibition concentration (MIC) mg/ mL of synthetic compounds 1–27.
| Comp. | Minimum Inhibition Concentration (MIC) mg/mL | |||
|---|---|---|---|---|
|
|
|
|
| |
|
| 125 | 250 | 250 | 250 |
|
| 500 | - | - | - |
|
| 500 | - | 250 | - |
|
| - * | - | - | - |
|
| - | - | - | - |
|
| - | - | - | - |
|
| 100 | 250 | 150 | 125 |
|
| 125 | 125 | 125 | 100 |
|
| 120 | 150 | 100 | 100 |
|
| - | 500 | 500 | 250 |
|
| - | - | - | 500 |
|
| 500 | 500 | 500 | - |
|
| 31 | 50 | 63 | 100 |
|
| 125 | 200 | 125 | 125 |
|
| 50 | 50 | 31 | 50 |
|
| - | - | - | - |
|
| - | - | - | - |
|
| - | - | - | - |
|
| - | - | - | - |
|
| - | - | - | - |
|
| - | - | - | - |
|
| 100 | 110 | 120 | 115 |
|
| 90 | 90 | 100 | 95 |
|
| 95 | 100 | 110 | 100 |
|
| 150 | 120 | 125 | 118 |
|
| 125 | 110 | 92 | 100 |
|
| 130 | 110 | 100 | 105 |
*(-) indicates no activity.